作者：
Arneric, Stephen P. [1]
;
Cedarbaum, Jesse M. [2]
;
Khozin, Sean [3]
;
Papapetropoulos, Spyros [4]
;
Hill, Derek L. [5]
;
Ropacki, Michael [6]
;
Rhodes, Jane [7]
;
Dacks, Penny A. [8]
;
Hudson, Lynn D. [9]
;
Gordon, Mark Forrest [10]
;
Kern, Volker D. [11]
;
Romero, Klaus [12]
;
Vradenburg, George [13]
;
Au, Rhoda [14]
;
Karlin, Daniel R. [15]
;
Facheris, Maurizio F. ;
Fitzer-Attas, Cheryl J. ;
Vitolo, Ottavio V. ;
Wang, Jian ;
Miller, Bradley M. ;
Kaye, Jeffrey A.
作者单位：
Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[1]
UsAgainstAlzheimers, Washington, DC USA
[2]
IXICO, London, England
[3]
Boston Univ, Boston, MA 02215 USA
[4]
Loma Linda Univ, Loma Linda, CA 92350 USA
[5]
Pfizer, Boston, MA USA
[6]
AbbVie, N Chicago, IL USA
[7]
TEVA, Cambridge, MA USA
[8]
Biogen, Cambridge, MA USA
[9]
Crit Path Inst, Tucson, AZ 85718 USA
[10]
CHDI Fdn, Princeton, NJ USA
[11]
US FDA, Bethesda, MD 20014 USA
[12]
Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA
[13]
Eli Lilly & Co, Indianapolis, IN 46285 USA
[14]
Alzheimers Drug Discovery Fdn, New York, NY USA
[15]
发布时间
2020-08-19
换一批
